Intermed OEM

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Intermed OEM - Medical Product Outsourcing

Search by

COMPANY SPOTLIGHT

itech

Saint-Gobain Medical

NN Medical

Lighteum Medical

Intermed OEM

Company Headquarters

2200 Northwestern Avenue, Racine, WI, 53404

Driving Directions Phone: View Phone

View website

Request more information from Intermed OEM

Yes, Please subscribe me to your weekly eNewsletters and Alerts

Yes, I wish to receive special promotions and offers from your affiliates.

Yes, I would like to learn more about Intermed OEM. Please contact me by Phone or Email

By completing this form, you are accepting our Terms of Use and Privacy Policy.

Categories from Intermed OEM

All Medical Device Categories

Related Content

OEM News

Patient Enrollment Begins in Study of AngioDynamics’ AlphaVac F1885 System

Trial is enrolling patients with confirmed acute, intermediate-risk pulmonary embolism at up to 20 sites in Europe, Canada, and Hong Kong.

By: Michael Barbella

OEM News

Study Begins for AngioDynamics’ AlphaVac F18⁸⁵ System

Multi-center, multi-national trial to evaluate mechanical thrombectomy treatment in acute, intermediate-risk PE patients in Europe.

Regulatory

FDA Clears RebrAIn’s OptimMRI Software

Company has expanded the software's capabilities to include the infero-lateral part of the ventralis intermedius nucleus.

OEM News

Jupiter Endovascular Nabs IDE Nod for Vertex Pulmonary Embolectomy Trial

The SPIRARE II trial will enroll up to 145 patients with acute, intermediate-risk pulmonary embolism.

OEM News

AngioDynamics Shares Positive Study Results for AlphaVac System

New data finds the device is safe in patients with acute intermediate-risk pulmonary embolism.

OEM News

Abbott Enrolls 1st Patient in Navitor TAVI Trial for Low and Intermediate Surgical Risk

The Navitor TAVI features a NaviSeal fabric cuff that reduces blood backflow around the heart valve.

Regulatory

French Regulators Recommend Coverage for HIFU Prostate Cancer Treatment

The National Authority for Health opinion relates to high-intensity focused ultrasound as a primary treatment for intermediate localized prostate cancer risk.